Clinical trial Recruiting at 1 site Interventional Ages 18 and up

PENG versus femoral nerve block for hip fracture pain

Official title: PENG vs Femoral Block for Hip Fracture, A Pragmatic Cluster-Randomized Study

Run by Weill Medical College of Cornell University · NCT07073209 · Data updated 2026-11-12

This will test whether a PENG nerve block or a femoral nerve block gives better pain relief and reduces opioid use for adults with confirmed hip fractures who agree to a nerve block.

More Hip Fractures trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment352 (estimated)
SponsorWeill Medical College of Cornell University
Academic / other
Locations1 site (Manhattan, New York)
StatusRecruiting
StartedJuly 10, 2025
Main results expectedMarch 2027
Study endsApril 2027
Registry record updatedMay 15, 2026
Trial IDNCT07073209 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (≥18) with radiologically confirmed hip fractures who are medically stable (ASA 1–4), able to consent and report pain, and willing to receive a peripheral nerve block.

Probably not a fit

Patients with altered mental status limiting pain reporting, allergy or contraindication to the block medications, or chronic preoperative opioid use are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, alternating-month design compares ultrasound-guided Pericapsular Nerve Group (PENG) blocks to traditional femoral nerve blocks in adults presenting with radiologically confirmed hip fractures. Participants presenting during each four-week period receive the designated block, with standard local anesthetic (bupivacaine with epinephrine) and optional dexamethasone per protocol. Outcomes include pain scores, opioid consumption, incidence of confusional state/delirium, and time to mobilization, and a prespecified subgroup analysis will compare intracapsular versus extracapsular fractures. Eligible patients are adults (≥18 years) with ASA 1–4 who can consent and report pain and have no chronic preoperative opioid use or contraindications to peripheral nerve blocks.

Why it matters

Potential benefit: If successful, the PENG block could provide better pain control with lower opioid requirements and faster mobilization after hip fracture.

How similar studies have gone: Early case series and a randomized comparison to placebo have shown meaningful pain reductions with the PENG block, while femoral blocks have established benefits versus placebo in multiple studies and a Cochrane review.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female ≥ 18 years of age.
2. ASA Classification 1-4
3. Documentation of a hip fracture diagnosis along with radiologic read indicating fracture location
4. Written, informed consent for analgesic peripheral block placement

Exclusion Criteria:

1. Altered mental status to the extent that it limits ability to report pain score
2. Patient or health care proxy refusal of analgesic nerve block
3. Allergy to study medications or contraindication to peripheral nerve block
4. Peri-prosthetic fracture
5. Any additional fractures in a patient with a unilateral hip fracture

Where it's running

  • Weill Cornell Medicine
    Manhattan, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Tiffany Tedore, MD — Weill Medical College of Cornell University
  • Study coordinator: Michele Steinkamp, BSN, RN
  • Email: mls9004@med.cornell.edu
  • Phone: 212-746-2953

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.